Nightingale Health Oyj has developed a biomarker profiling technology widely used in population health research. Nightingale has measured biomarkers from 40,000 samples from THL biobank cohorts. The aim of this THL Biobank project is to continue research on the existing NMR biomarker data for precision medicine research. The research will also help further developments of this technology in healthcare. The project duration has been extended by THL Biobank. Here the data analyst team is updated.
Changes to the permit: change of processors
Issuer of the original permit: Findata; other than Findata